Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats

BMC Nephrol. 2020 May 29;21(1):206. doi: 10.1186/s12882-020-01861-2.

Abstract

Background: Previous study showed that purinergic P2X7 receptors (P2X7R) reach the highest expression in the first week after unilateral ureteral obstruction (UUO) in mice, and are involved in the process of inflammation, apoptosis and fibrosis of renal tissue. We, herein, document the role of purinergic P2X7 receptors activation on the third day of UUO, as assessed by means of BBG as its selective inhibitor.

Methods: We investigated the effects of brilliant blue G (BBG), a P2X7R antagonist, in the third day of kidney tissue response to UUO in rats. For this purpose, male Wistar rats submitted to UUO or sham operated, received BBG or vehicle (V), comprising four groups: UUO-BBG, UUO-V, sham-BBG and sham-V. The kidneys were harvested on day 3 UUO and prepared for histology, immunohistochemistry (P2X7R, PCNA, CD-68, α-sma, TGF-β1, Heat-shock protein-47, TUNEL assay), quantitative real-time PCR (IL-1β, procollagens type I, III, and IV) for mRNA quantification.

Results: The group UUO-V presented an enhancement in tubular cell P2X7-R expression, increase influx of macrophages and myofibroblasts, HSP-47 and TGF- β1 expression. Also, upregulation of procollagen types I, III, and IV, and IL-1β mRNAs were seen. On the other hand, group UUO-BBG showed lower expression of procollagens and IL-1β mRNAs, as well as less immunoreactivity of HSP-47, TGF-β, macrophages, myofibroblasts, and tubular apoptosis. This group also presented increased epithelial cell proliferation.

Conclusion: BBG, a known highly selective inhibitor of P2X7R, attenuated renal inflammation, collagen synthesis, renal cell apoptosis, and enhanced renal cell proliferation in the early phase of rat model of UUO.

Keywords: Macrophages; P2X7 receptor; Renal inflammation; Unilateral ureteral obstruction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Apoptosis / drug effects
  • Cell Movement
  • Cell Proliferation / drug effects*
  • Collagen Type I / genetics
  • Collagen Type III / genetics
  • Collagen Type IV / genetics
  • Fibrosis
  • HSP47 Heat-Shock Proteins / metabolism
  • Interleukin-1beta / genetics
  • Kidney / metabolism
  • Kidney / pathology*
  • Kidney Tubules / pathology
  • Macrophages / physiology
  • Male
  • Myofibroblasts / physiology
  • Nephritis / drug therapy*
  • Nephritis / etiology
  • Purinergic P2X Receptor Antagonists / pharmacology
  • Purinergic P2X Receptor Antagonists / therapeutic use*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Rosaniline Dyes / pharmacology
  • Rosaniline Dyes / therapeutic use*
  • Time Factors
  • Transforming Growth Factor beta1 / metabolism
  • Up-Regulation
  • Ureteral Obstruction / complications*

Substances

  • Acta2 protein, rat
  • Actins
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 protein, rat
  • Collagen Type I
  • Collagen Type III
  • Collagen Type IV
  • HSP47 Heat-Shock Proteins
  • IL1B protein, rat
  • Interleukin-1beta
  • Purinergic P2X Receptor Antagonists
  • RNA, Messenger
  • Rosaniline Dyes
  • Serpinh1 protein, rat
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1
  • coomassie Brilliant Blue